Report on the Drug Situation 2010 - Bundesministerium für ...

play the most important role in the context of substance use that requires treatment
(see, e.g., EMCDDA 2009). The share of cannabis named as a primary drug is between
17% and 32%, depending on the setting. In part, this has to be qualified, however,
because a very high percentage of clients who only use cannabis have been referred to
compulsory treatment: for instance, this applies to 61% of people undergoing longterm
outpatient treatment (see also Chapter 4.1).
Figure 5.2
People entering drug-related treatment, by primary drug and type of service
Share of clients by primary drug
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
80%
56%
54%
40%
20%
13%
9%
11%
8%
3% 3%
1%
22%
14%
10% 11%
0% 0% 1%
2%
34%
30%
22%
20%
8%
6% 6% 5%
Opioids Cocaine Stimulants Tranquilisers/
hypnotics
Hallucinogenic
drugs
Cannabis
Alcohol
Short term contacts (n = 5 513) Low-threshold services (n = 580)
Long-term outpatient treatment (n = 3 591) Long-term inpatient treatment (n = 1 476)
Note: Multiple answers were permitted.
Source: GÖG/ÖBIG 2010a, DOKLI analysis of client year 2009; representation by GÖG/ÖBIG
Approximately half of the clients turning to the respective services (except short-term
contacts, where this aspect is not documented) have already entered opioid
substitution treatment (OST started in the course of the provision of drug-related
services is not documented in this context), with the share of clients undergoing
substitution treatment rising with age.
The DOKLI data of 2009 confirm former results regarding the great relevance of
snorting also among users of heroin or other opioids, which is important with regard
to harm reduction.
46 © GÖG/ÖBIG, <strong>Report</strong> on the Drug Situation 2010